Omaxe Limited

Pervasive negative margins: OPM ranged -22.71% to -65.68% across recent quarters (most at -50%+), suggesting structural cost or project-mix misalignment rather than cyclical weakness

Equity erosion from sustained losses: Nine of ten recent quarters show negative net profit; Mar 2026 lost ₹191.42 Cr, Sep 2025 lost ₹166.42 Cr — verify whether negative equity has triggered debt covenant pressure

Dividend cessation since Sep 2019 signals cash-generation failure — no payouts despite historical annual distributions; assess working-capital stress and debt service capacity

Verify project pipeline health: No visibility to launch momentum, pre-sales, or completion schedules — real estate risk depends critically on these execution metrics

Jun 2026 Q2 posted 1.8% OPM and ₹1.3 Cr net profit (0.05 EPS) — if this quarter marks inflection from structural losses, signals path to profitability

Revenue sustained ₹300–400 Cr quarterly (Jun ₹406 Cr, Dec ₹301 Cr, Sep ₹320 Cr) indicates active projects despite losses — verify if recent quarters reflect project completions and deliveries

Stock trading at 52-week high (₹99.14 vs ₹64.09–₹99.14 range) suggests market pricing recovery — verify whether this reflects pre-sales momentum or diverges from underlying project execution

Data hints at segment divergence (Jun 2026 shows one segment profitable, one loss-making) — if residential or commercial recovers independently, could stabilize group profitability